Back to Search
GREGORY MASTERS, MD
MD
Medical Oncology Physician
NPI: 1508834680IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
C10006866(DE)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
NORTHWESTERN UNIVERSITY FEINBERG MEDICAL SCHOOL
Class of 1990
Research & Publications (20)
A randomized phase II trial using two different treatment schedules of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer.
PMID 17409822·J Thorac Oncol·2006
3-trial
A phase II trial of carboplatin and gemcitabine with exisulind (IND #65,056) in patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (E1501).
PMID 17409935·J Thorac Oncol·2006
3-trial
Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group Trial 1597.
PMID 12697880·J Clin Oncol·2003
3-trial
Synergistic effects of combined therapy using paclitaxel and [90Y-DOTA]776.1 on growth of OVCAR-3 ovarian carcinoma xenografts.
PMID 16434088·Gynecol Oncol·2006
7-preclinical
Pemetrexed in second line and beyond small cell lung cancer: a Hoosier Oncology Group phase II study.
PMID 19096313·J Thorac Oncol·2009
3-trial
Incidence of haemoglobinopathies in various populations - the impact of immigration.
PMID 19497317·Clin Biochem·2009
8-other
Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.
PMID 18281659·J Clin Oncol·2008
3-trial
Relationship between symptom change, objective tumor measurements, and performance status during chemotherapy for advanced lung cancer.
PMID 18282359·Clin Lung Cancer·2008
8-other
Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105.
PMID 18487565·J Clin Oncol·2008
3-trial
Expenditure on diabetes treatments and achievement of glycaemic control: retrospective analysis.
PMID 18544110·Diabet Med·2008
4-observational
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.
PMID 18281656·J Clin Oncol·2008
3-trial
Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study.
PMID 18758305·J Thorac Oncol·2008
3-trial
Can mass media campaigns change antimicrobial prescribing? A regional evaluation study.
PMID 17283035·J Antimicrob Chemother·2007
8-other
An innovative symptom monitoring tool for people with advanced lung cancer: a pilot demonstration.
PMID 17944147·J Support Oncol·2007
8-other
Nutrition surveys or surveillance: one-night stands or a long-term commitment?
PMID 16948618·Med J Aust·2006
8-other
Topotecan therapy in patients with relapsed small-cell lung cancer and poor performance status.
PMID 17026814·Clin Lung Cancer·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4701 OGLETOWN-STANTON RD.
NEWARK, DE 19713 - Phone
- (302) 366-1200
Quick Facts
- NPI
- 1508834680
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile